Medicare billing address
CMS Medicare provider billing file
1950 Circle Of Hope DrSalt Lake City, UT 84112
CMS public data · NPI 1518209485
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Benjamin L Solomon, M.D.
Specialty
Credential
M.D.
NPI
1518209485
Primary source state
UT
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Benjamin L Solomon, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1950 Circle Of Hope DrCMS Doctors & Clinicians file
3592 W 9000In the 2024 CMS provider billing file, this NPI had 222 Medicare beneficiaries and 77,457 total services. The average beneficiary age was 74, and the average HCC risk score was 2.
Total Medicare allowed amount
$1,802,442.29
Total Medicare payment amount
$1,435,085.22
Medicare beneficiaries
222
Total services
77,457
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
66%
CMS beneficiary-panel share
Hyperlipidemia
60%
CMS beneficiary-panel share
Diabetes
32%
CMS beneficiary-panel share
Chronic kidney disease
29%
CMS beneficiary-panel share
Depression
27%
CMS beneficiary-panel share
Mood disorders
27%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, denosumab, 1 mg | 4,140 | $25.59 |
| Injection, dexamethasone sodium phosphate, 1 mg | 1,160 | $0.11 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 588 | $7.57 |
| Blood test, comprehensive group of blood chemicals | 522 | $10.27 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 243 | $122.55 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 223 | $26.48 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 191 | $87.31 |
| Administration of chemotherapy into vein, 1 hour or less | 148 | $119.47 |
| Gammaglobulin (immune system protein) measurement | 123 | $9.11 |
| Lactate dehydrogenase (enzyme) level | 109 | $5.87 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1518209485. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Anastrozole | Anastrozole | 112 | 337.7 | $1,774.42 |
| 2 | Imbruvica | Ibrutinib | 71 | 71 | $1,138,399.52 |
| 3 | Prednisone | Prednisone | 62 | 83.3 | $233.36 |
| 4 | Hydroxyurea | Hydroxyurea | 35 | 93 | $1,456.83 |
| 5 | Tamoxifen Citrate | Tamoxifen Citrate | 33 | 67.9 | $997.44 |
| 6 | Calquence | Acalabrutinib Maleate | 25 | 25 | $364,533.24 |
| 7 | Abiraterone Acetate | Abiraterone Acetate | 24 | 24 | $3,886.53 |
| 8 | Ondansetron Odt | Ondansetron | 22 | 22 | $468.12 |
| 9 | Prochlorperazine Maleate | Prochlorperazine Maleate | 22 | 22 | $312.05 |
| 10 | Ibrance | Palbociclib | 21 | 23.6 | $194,526.84 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Medical College Of Georgia School Of Medicine
Graduation year
2013
Group/practice field
Utah Cancer Specialists Pc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.